Devices › Device types
FDA product code KPO · class 2 · Gastroenterology, Urology
Dialysate concentrate for hemodialysis (liquid or powder): medical device reports filed with FDA
30,009 reports carry this product code, 1992–2026; 9 brands with a page.
- 30,009
- reports with this product code
- 0.1% of all MAUDE reports
- 125
- reports, 12 months to August 2026
- 103 in the 12 months before
- 5%
- classified as malfunction
- 62.3% across all reports
- 76.9%
- classified as death, as reported
- 0.9% across all reports
Product code KPO is FDA's classification for "Dialysate concentrate for hemodialysis (liquid or powder)" (gastroenterology, Urology panel), a class 2 device. 30,009 medical device reports carry this product code, 0.1% of the MAUDE database, from June 1992 to August 2026.
125 reports arrived in the 12 months to August 2026, up 21% from 103 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are death (76.9%), injury (17.8%) and malfunction (5%). 9 brand names with a page on this site carry this code; the brands table is ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Brands with this product code
| Brand | Reports | Latest 12 months | Classified as death | Classified as malfunction |
|---|---|---|---|---|
| Granuflo | 13,856 | 0 | 82.1% | 0% |
| Naturalyte | 13,746 | 0 | 82.2% | 0% |
| NxStage System One | 238 | 120 | 5.7% | 21.2% |
| Accusol | 236 | 0 | 0% | 99.6% |
| Fresenius 2008k | 12 | 0 | 76.8% | 0.3% |
| B Braun | 2 | 12 | 3% | 77.8% |
| Fresenius | 2 | 0 | 6.1% | 13.7% |
| Dialyzer | 1 | 69 | 2.2% | 57.4% |
| Tandem T Slim Insulin Delivery System | 1 | 0 | 0.1% | 65.2% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Manufacturers named
| Manufacturer (as written on reports) | Reports | Share |
|---|---|---|
| Fresenius Medical Care North America | 28,059 | 93.5% |
| Nxstage Medical | 331 | 1.1% |
| Concord Manufacturing | 258 | 0.9% |
| Erika De Reynosa De C V | 28 | 0.1% |
| Baxter Healthcare - Cali | 16 | 0.1% |
| Gambro Healthcare | 14 | 0% |
| Fresenius USA | 9 | 0% |
| Baxter Hlthcare | 1 | 0% |
| Ogden Manufacturing Plant | 1 | 0% |
| Vantive US Healthcare | 1 | 0% |
Reports by month, five years
FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
Event type and report source
Event type
Who filed
Grey bar: all 26,136,888 MAUDE reports.
Device problems coded
| Device problem (FDA code) | Reports | Share |
|---|---|---|
| Insufficient device problem information | 27,821 | 92.7% |
| Breakthe device broke | 310 | 1% |
| Leak/splashthe device leaked | 270 | 0.9% |
| Fluid/blood leak | 243 | 0.8% |
| Chemical problem | 210 | 0.7% |
| Thermal decomposition of device | 179 | 0.6% |
| Precipitate in device or device ingredient | 152 | 0.5% |
| Smoking | 99 | 0.3% |
| Material separation | 49 | 0.2% |
| Melted | 47 | 0.2% |
| Device contaminated during manufacture or shipping | 43 | 0.1% |
| Device operates differently than expectedthe device behaved unexpectedly | 35 | 0.1% |
| Defective component | 31 | 0.1% |
| Detachment of device or device componentpart of the device came off | 29 | 0.1% |
| Fire | 28 | 0.1% |
| Sparking | 26 | 0.1% |
| Improper or incorrect procedure or method | 25 | 0.1% |
| Detachment of device component | 24 | 0.1% |
| Material discolored | 23 | 0.1% |
| Contamination | 22 | 0.1% |
Questions about dialysate concentrate for hemodialysis (liquid or powder) reports
What is product code KPO?
FDA's classification code for "Dialysate concentrate for hemodialysis (liquid or powder)", class 2, reviewed by the gastroenterology, Urology panel. Every device report carries the product code of the device involved.
How many reports carry this code?
30,009 reports through August 2026, 125 of them in the latest 12 months.
Which brands appear most often?
Granuflo (13,856), Naturalyte (13,746), NxStage System One (238), Accusol (236) and Fresenius 2008k (12). Widely used products collect more reports because more people use them.
Can the brands table be used to rank the devices?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." Brands differ in how many are in use, how long they have been sold and how reports are collected.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.